Pr Eric E. Gabison

Current position

Full professor and hospital practitioner (PU-PH). Head of the ophthalmology department at the Adolphe de Rothschild Foundation (Paris). Director of the laboratory for translational research and experimental corneal surgery (T-REX). Head of the national referral centre for rare eye diseases. Specialised in complex corneal surgery (endothelial and lamellar keratoplasty), cataract surgery and refractive surgery.

Education & qualifications

Medical track

• 2014Full professor – hospital practitioner (PU-PH), Université Paris Cité
• 2012–2014Associate professor – hospital practitioner (MCU-PH)
• 2010European Board of Ophthalmology (EBO)
• 2008–2013University hospital practitioner (PHU), Bichat – Rothschild Foundation
• 2003–2008Clinical chief – assistant then associate, Bichat Hospital (Prof. Hoang-Xuan)
• 2003MD, Paris VII Faculty of Medicine
• 1996–2002Surgical residency, Paris
• 1996Paris hospitals residency competition, surgery (ranked 1st)

Scientific track

• 2010Accreditation to supervise research (HDR), Université Paris VII
• 2008PhD, St-Louis Hospital, Université Paris VII
• 1999–2001Cornea and Refractive Surgery Research Fellow – Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, USA
• 1999Master’s research degree (DEA), epithelial pathology, Paris VII
• 1996Master of biological and medical sciences, Paris XII

Research

Projects & clinical trials (principal investigator)

• PHRC-N (2025–2030) – Cell therapy for ocular GVHD (MINING) – PI
• PHRC-N (2025–2030) – Cell therapy for chemical burns (SYMBOL) – PI
• PEPR COBRAS (2025–2029) – biotherapy & bioproduction – PI
• Téléthon strategic programme MICELLES (2024–2027) – PI
• CASCADE (FP7) – cell therapy for ocular burns – Work Package lead
• Cohorts: dry eye (ALTESSE), keratoconus (KERMIT), genetic limbal deficiency (SILOG-PRIMA-TALEN), herpetic keratitis

Team leadership

• Since 2018 – Director of the T-REX laboratory (Rothschild Foundation)
• 2013–2020 – INSERM UMR-S 976, Skin Research Institute (St-Louis)
• 2008–2013 – Vision Institute (XV-XX) · 2005–2008 – CNRS UMR 7142

Awards

• Lally Fellowship 2000 (Harvard Medical School)
• Dalloz Prize for ophthalmology research 2011 (Institut de France)

Teaching

• Examiner, European Board of Ophthalmology (since 2008)
• Lead / lecturer for several university diplomas: burns medicine, cell therapy, ocular surface, ocular inflammation & infection, ophthalmic drugs
• Undergraduate and ophthalmology residents teaching, Université Paris VII / Paris Cité
• Master’s “Epithelial pathology” – cornea module

Clinical & surgical activity

• Specialist clinics: corneal grafts (follow-up, rejection, astigmatism), inflammatory disease (scleritis, uveitis), infections (keratitis, endophthalmitis), wound-healing disorders, burns, dystrophies, keratoconus, rare genetic diseases (ligneous conjunctivitis, aniridia)
• Anterior segment surgery: corneal grafts (DALK, DMEK, DSAEK, penetrating), cataract, reconstruction (amniotic membrane, limbus), refractive surgery (LASIK, PRK, PTK)

Responsibilities & expertise

• Editorial board, “The Ocular Surface” · Scientific board, TFOS (Tear Film & Ocular Surface Society)
• Biovigilance correspondent (Rothschild Foundation) · Board, French Eye Bank
• Expert reviewer: ANSM, AP-HP, ANR, Fondation de l’Avenir

International collaborations

Publications

116 publications in indexed journals, 14 as first author and 34 as senior author. See the complete list and the papers explained →

Book chapters

• Gabison EE. Corneal wound-healing agents. In: Médicaments et biothérapies en ophtalmologie — French Society of Ophthalmology 2023 Report, chapter 21. Elsevier Masson. Full text, open access